Skip to main content

Tata Steel reports consolidated Q1 loss at Rs 4,648 crore; management says worst is behind it

 Total revenue from operations fell to Rs 24,288.51 crore in Q1 FY21 against Rs 33,769.95 crore sequentially and Rs 35,947.11 crore year-on-year

 

Tata Steel, on August 13, reported a consolidated net loss of Rs 4,648.13 crore for the June quarter of FY21. It had reported a loss of 1,615.35 crore in the March quarter and a profit of Rs 714.03 crore in the June quarter of FY20.

Total revenue from operations fell to Rs 24,288.51 crore in Q1 FY21 against Rs 33,769.95 crore sequentially and Rs 35,947.11 crore year-on-year.

Adjusted EBITDA came in at Rs 1,038 crore against Rs 5,530 crore YoY and Rs 4,869 crore QoQ.


On a standalone basis, the company reported a profit of Rs 1,193.27 crore for Q1 FY21 against a profit of Rs 1,538.99 crore YoY and a loss of Rs 436.83 crore QoQ.

The management said its operating level has recovered to 90 percent by June 30 and has since then increased further to 95 percent.

"India's average steel realisations were lower due to the COVID impact during Q1. About Rs 2,000 crore of costs were under absorbed due to the lower volumes and have been charged to the profit and loss account," the company said.

Despite the drop in margins, there was a reduction in net debt of Rs 1,677 crore in India, including a reduction of Rs 577 crore and Rs 291 crore at Tata Steel BSL and Tata Steel Long Products, respectively.

The management said that given the uncertain economic environment, it has built up a liquidity buffer of Rs 20,144 crore, including Rs 14,178 crore of cash and cash equivalents.

Commenting on the quarterly performance, TV Narendran, CEO and Managing Director, said: "We were successful in mitigating the impact of COVID-19 as we pivoted the business towards export markets and successfully generated free cash flows despite adverse market conditions."

Narendran said he is cautiously optimistic that 'the worst is behind us'.

Koushik Chatterjee, Executive Director and CFO, said: "Tata Steel Europe's performance was affected by lower deliveries and a sharp decline in European spreads to an unsustainably low level. As a result, our consolidated adjusted EBITDA dropped to Rs 1,038 crore."

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more